Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

iShares U.S. Pharmaceuticals ETF (IHE)

Delayed Data
As of Aug 28
 +0.70 / +0.41%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index (the "underlying index"), which measures the performance of the pharmaceuticals sector of the U.S. equity market. The fund is non-diversified.

No recent news for iShares U.S. Pharmaceuticals ETF.


1 month-6.86% 3 years+26.67%
3 months-4.09% 5 years+26.11%
1 year+25.03% Since inception+15.57%
Data through 08/29/2015

Quote Details

Previous close$168.85
Open day’s range167.56 – 169.55
Net asset value (NAV)169.57 (08/28/2015)
Daily volume47,543
Average volume (3 months)55,614
Data as of 3:59pm ET, 08/28/2015

Peer Comparisonvs. Health ETFs

Performance 5-yr return+26.11%+26.72%
Expense Gross exp ratio0.45%0.46%
Risk 5 year sharpe ratio2.081.76
Net assets$1.3B$2.2B
Average market cap$23.8B$38.7B
Average P/E26.926.0
Dividend / Share--0.21%


XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 98.99%
Consumer goods 1.01%
Business service 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
JNJ Johnson & Johnson9.16%
PFE Pfizer8.60%
MRK Merck7.43%
AGN Allergan7.22%
BMY Bristol-Myers Squibb6.37%
LLY Eli Lilly and Co5.78%
PRGO Perrigo Company PLC3.86%
ZTS Zoetis Inc3.58%
ANAC Anacor Pharmaceuticals Inc3.50%
ENDP Endo International PLC3.32%

Partner Offers